Swedbank’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,400
Closed -$161K 713
2023
Q2
$161K Sell
13,400
-4,100
-23% -$55.9K ﹤0.01% 692
2023
Q1
$228K Hold
17,500
﹤0.01% 692
2022
Q4
$259K Hold
17,500
﹤0.01% 687
2022
Q3
$155K Hold
17,500
﹤0.01% 719
2022
Q2
$221K Hold
17,500
﹤0.01% 717
2022
Q1
$331K Hold
17,500
﹤0.01% 725
2021
Q4
$617K Hold
17,500
﹤0.01% 718
2021
Q3
$641K Hold
17,500
﹤0.01% 711
2021
Q2
$687K Hold
17,500
﹤0.01% 707
2021
Q1
$494K Buy
+17,500
New +$558K ﹤0.01% 710

Other funds holding HCM

Swedbank's HCM Position: Q3 2023 in Review

Swedbank sold out of HUTCHMED (HCM) in Q3 2023, closing a stake of 13,400 shares — an estimated $161K sold.

Swedbank first reported a position in HCM in Q1 2021 and held it in 10 quarters. The position peaked at $687K in Q2 2021. 65 funds tracked by Wall St. Rank hold HCM as of Q3 2023.

  • Swedbank reported no remaining HUTCHMED position as of Q3 2023 after selling out during the quarter.
  • Swedbank sold 13,400 HUTCHMED shares in Q3 2023, an estimated $161K.
  • Swedbank first reported a position in HUTCHMED in Q1 2021 and held it in 10 quarters.
  • Swedbank's HUTCHMED position peaked at $687K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held HUTCHMED as of Q3 2023.

Based on Swedbank's 13F filing for Q3 2023, filed 6 Dec 2024.